Appendix C to Part 40 - DOT Drug-Testing Semi-Annual Laboratory Report to DOT
49:1.0.1.1.30.20.43.1.30 : Appendix C
Appendix C to Part 40 - DOT Drug-Testing Semi-Annual Laboratory
Report to DOT
Mail, fax, or email to:
U.S. Department of Transportation, Office of Drug and Alcohol
Policy and Compliance, W62-300, 1200 New Jersey Avenue SE.,
Washington, DC 20590,
Fax: (202) 366-3897,
Email:
[email protected].
The following items are required on each report:
Reporting Period: (inclusive dates) Laboratory Identification:
(name and address) 1. DOT Specimen Results Reported (total number)
2. Negative Results Reported (total number) Negative (number)
Negative-Dilute (number) 3. Rejected for Testing Results Reported
(total number) By Reason (a) Fatal flaw (number) (b) Uncorrected
Flaw (number) 4. Positive Results Reported (total number) By Drug
(a) Marijuana Metabolite (number) (b) Cocaine Metabolite (number)
(c) Opioids (number)
(1) Codeine (number)
(2) Morphine (number)
(3) 6-AM (number)
(4) Hydrocodone (number)
(5) Hydromorphone (number)
(6) Oxycodone (number)
(7) Oxymorphone (number)
(d) Phencyclidine (number) (e) Amphetamines (number)
(1) Amphetamine (number)
(2) Methamphetamine (number)
(3) MDMA (number)
(4) MDA (number)
5. Adulterated Results Reported (total number) By Reason (number)
6. Substituted Results Reported (total number) 7. Invalid Results
Reported (total number) By Reason (number) [82 FR 52247, Nov. 13,
2017]